arrow
Back
J

Janice M. Mehnert

rutgers university system

33H-index
141Paper Count
6.6KCitation Count
Published Papers 33
Publication Date
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
err2025-01-01
err0
PREAI
errHandel, Eleanor E.; Mckeown, Janet; Wei, Joe; Kankaria, Roma A.; Burnette, Hannah; Johnson, Douglas B.; Lawless, Aleigha; Czapla, Juliane; Sullivan, Ryan J.; Albrecht, Lea Jessica; Zimmer, Lisa; Mangana, Joanna; Dummer, Reinhard; Kessels, Jolien I.; Neyns, Bart; Allayous, Clara; Lebbe, Celeste; Boatwright, Christina; Mehnert, Janice M.; Ottaviano, Margaret; Ascierto, Paolo A.; Czarnecka, Anna M.; Rutkowski, Piotr; Lo, Serigne N.; V. Long, Georgina; Menzies, Alexander M.; Carlino, Matteo S.
errShare
errSave
KEYMAKER-U02 substudy 02C: Neoadjuvant pembrolizumab (pembro) and investigational agents followed by adjuvant pembro for stage IIIB-D melanoma
err2024-09-01
err4
PREAI
errLong, G. V.; Robert, C.; Hill, A. G.; Marqueste, C. Gaudy; Portnoy, D.; Shapira, R.; Cohen, J. E.; Khattak, M. A.; Lebbe, C.; Menzies, A. M.; Markel, G.; Bar-Sela, G.; Sharfman, W. H.; Pages, C.; Hamid, O.; Mehnert, J. M.; Jing, N.; Kalabis, M.; Krepler, C.; Dummer, R.
errShare
errSave
A phase I clinical trial evaluating exarafenib, a selective pan-RAF inhibitor in combination with binimetinib in NRAS-mutant (NRASMut) melanoma (Mel) & BRAF-altered solid tumors
err2024-09-01
err1
PREAI
errCassier, P.; Mehnert, J. M.; Kim, R.; Chmielowski, B.; Millward, M.; Perez, C. A.; Gonzalez Cao, M.; Gambardella, V.; Mckean, M.; Brose, M. S.; Xing, Y.; Long, G. V.; Kelly, A.; Lee, G.; Severson, P.; Williams, R.; Marqueste, C. Gaudy
errShare
errSave
Expanding access to early phase trials: the CATCH-UP.2020 experience
err2022-12-16
err1
errOAAI
errBaranda, Joaquina C.; Diaz, Francisco J.; Rubinstein, Larry; Shields, Anthony F.; Dayyani, Farshid; Mehta, Amitkumar; Mehnert, Janice M.; Trent, Jonathan; Mabaera, Rodwell; Mooney, Margaret; Moscow, Jeffrey A.; Doroshow, James; Waters, Brittany; Ivy, Percy; Gore, Steven D.; Thomas, Alexandra
errShare
errSave
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities
err2022-09-01
err9
errOAAI
errKarz, Alcida; Dimitrova, Maya; Kleffman, Kevin; Alvarez-Breckenridge, Christopher; Atkins, Michael B.; Boire, Adrienne; Bosenberg, Marcus; Brastianos, Priscilla; Cahill, Daniel P.; Chen, Qing; Ferguson, Sherise; Forsyth, Peter; Oliva, Isabella C. Glitza; Goldberg, Sarah B.; Holmen, Sheri L.; Knisely, Jonathan P. S.; Merlino, Glenn; Nguyen, Don X.; Pacold, Michael E.; Perez-Guijarro, Eva; Smalley, Keiran S. M.; Tawbi, Hussein A.; Wen, Patrick Y.; Davies, Michael A.; Kluger, Harriet M.; Mehnert, Janice M.; Hernando, Eva
errShare
errSave
Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma
errCANCER
IF5.1
err2022-08-25
err2
errOAAI
errJohannet, Paul; Simons, Morgan; Qian, Yingzhi; Azmy, Nadine; Mehnert, Janice M.; Weber, Jeffrey S.; Zhong, Judy; Osman, Iman
errShare
errSave
Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?
err2022-06-04
err10
PREAI
errBerger, Assaf; Bernstein, Kenneth; Alzate, Juan Diego; Mullen, Reed; Silverman, Joshua S.; Sulman, Erik P.; Donahue, Bernadine R.; Pavlick, Anna C.; Gurewitz, Jason; Mureb, Monica; Mehnert, Janice; Madden, Kathleen; Palermo, Amy; Weber, Jeffrey S.; Golfinos, John G.; Kondziolka, Douglas
errShare
errSave
Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up
err2021-12-01
err32
errOAAI
errD'Angelo, S. P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I; Lebbe, C.; Lewis, K. D.; Linette, G. P.; Milella, M.; Xiong, H.; Guezel, G.; Nghiem, P. T.
errShare
errSave
Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma
err2021-01-23
err15
PREAI
errKangas-Dick, Aaron W.; Greenbaum, Alissa; Gall, Victor; Groisberg, Roman; Mehnert, Janice; Chen, Chunxia; Moore, Dirk F.; Berger, Adam C.; Koshenkov, Vadim
errShare
errSave
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study
errCANCER
IF5.1
err2020-04-22
err102
errOAAI
errMehnert, Janice M.; Bergsland, Emily; O'Neil, Bert H.; Santoro, Armando; Schellens, Jan H. M.; Cohen, Roger B.; Doi, Toshihiko; Ott, Patrick A.; Pishvaian, Michael J.; Puzanov, Igor; Aung, Kyaw L.; Hsu, Chiun; Le Tourneau, Christophe; Hollebecque, Antoine; Elez, Elena; Tamura, Kenji; Gould, Marlena; Yang, Ping; Stein, Karen; Piha-Paul, Sarina A.
errShare
errSave
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors
err2019-08-06
err21
PREAI
errStein, Mark N.; Goodin, Susan; Gounder, Murugeson; Gibbon, Darlene; Moss, Rebecca; Portal, Daniella; Lindquist, Diana; Zhao, Yujie; Takebe, Naoko; Tan, Antoinette; Aisner, Joseph; Lin, Hongxia; Ready, Neal; Mehnert, Janice M.
errShare
errSave
Pembrolizumab after two or more lines of prior therapy in patients with advanced small-cell lung cancer (SCLC): Results from the KEYNOTE-028 and KEYNOTE-158 studies
err2019-07-01
err11
PREAI
errChung, Hyun Cheol; Piha-Paul, Sarina A.; Lopez-Martin, Jose; Schellens, Jan H. M.; Kao, Steven; Miller, Wilson H., Jr.; Delord, Jean-Pierre; Gao, Bo; Planchard, David; Gottfried, Maya; Zer, Alona; Jalal, Shadia I.; Penel, Nicolas; Mehnert, Janice M.; Matos, Ignacio; Bennouna, Jaafar; Kim, Dong-Wan; Xu, Lei; Krishnan, Suba; Norwood, Kevin; Ott, Patrick A.
errShare
errSave
Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma
err2019-06-20
err6
errOAAI
errPortal, Daniella E.; Weiss, Robert E.; Wojtowicz, Malgorzata; Mansour, Amal; Monken, Claude; Mehnert, Janice M.; Aisner, Joseph A.; Kane, Michael; Nishioka, Jennifer; Aisner, Seena; Peters, Stephen; Stein, Mark N.; Kim, Isaac Y.; Mayer, Tina M.; Shih, Weichung; Gulley, James; Streicher, Howard; Singer, Eric A.; Lattime, Edmund C.
errShare
errSave
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
err2019-05-22
err53
errOAAI
errStein, Mark N.; Malhotra, Jyoti; Tarapore, Rohinton S.; Malhotra, Usha; Silk, Ann W.; Chan, Nancy; Rodriguez, Lorna; Aisner, Joseph; Aiken, Robert D.; Mayer, Tina; Haffty, Bruce G.; Newman, Jenna H.; Aspromonte, Salvatore M.; Bommareddy, Praveen K.; Estupinian, Ricardo; Chesson, Charles B.; Sadimin, Evita T.; Li, Shengguo; Medina, Daniel J.; Saunders, Tracie; Frankel, Melissa; Kareddula, Aparna; Damare, Sherrie; Wesolowsky, Elayne; Gabel, Christian; El-Deiry, Wafik S.; Prabhu, Varun V.; Allen, Joshua E.; Stogniew, Martin; Oster, Wolfgang; Bertino, Joseph R.; Libutti, Steven K.; Mehnert, Janice M.; Zloza, Andrew
errShare
errSave
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
err2019-03-04
err162
errOAAI
errMehnert, Janice M.; Varga, Andrea; Brose, Marcia S.; Aggarwal, Rahul R.; Lin, Chia-Chi; Prawira, Amy; de Braud, Filippo; Tamura, Kenji; Doi, Toshihiko; Piha-Paul, Sarina A.; Gilbert, Jill; Saraf, Sanatan; Thanigaimani, Pradeep; Cheng, Jonathan D.; Keam, Bhumsuk
errShare
errSave
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer
err2018-09-14
err22
errOAAI
errKrishnamurthy, Anuradha; Dasari, Arvind; Noonan, Anne M.; Mehnert, Janice M.; Lockhart, Albert C.; Leong, Stephen; Capasso, Anna; Stein, Mark N.; Sanoff, Hanna K.; Lee, James J.; Hansen, Aaron; Malhotra, Usha; Rippke, Sarah; Gustafson, Daniel L.; Pitts, Todd M.; Ellison, Kim; Davis, S. Lindsey; Messersmith, Wells A.; Eckhardt, S. Gail; Lieu, Christopher H.
errShare
errSave
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
err2018-04-10
err43
errOAAI
errMehnert, Janice M.; Silk, Ann W.; Lee, J. H.; Dudek, Liesel; Jeong, Byeong-Seon; Li, Jiadong; Schenkel, Jason M.; Sadimin, Evita; Kane, Michael; Lin, Hongxia; Shih, Weichung J.; Zloza, Andrew; Chen, Suzie; Goydos, James S.
errShare
errSave
Safety Profile of Avelumab in Patients With Advanced Solid Tumors: A Pooled Analysis of Data From the Phase 1 JAVELIN Solid Tumor and Phase 2 JAVELIN Merkel 200 Clinical Trials
errCANCER
IF5.1
err2018-02-22
err76
errOAAI
errKelly, Karen; Infante, Jeffrey R.; Taylor, Matthew H.; Patel, Manish R.; Wong, Deborah J.; Iannotti, Nicholas; Mehnert, Janice M.; Loos, Anja H.; Koch, Helga; Speit, Isabell; Gulley, James L.
errShare
errSave
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
err2018-01-01
err15
PREAI
errOtt, Patrick A.; Bang, Yung-Jue; Berton-Rigaud, Dominique; Elez, Elena; Pishvaian, Michael J.; Rugo, Hope S.; Puzanov, Igor; Mehnert, Janice M.; Aung, Kyaw L.; Lopez, Juanita; Carrigan, Marion; Saraf, Sanatan; Chen, Mei; Soria, Jean-Charles
errShare
errSave
Pembrolizumab for patients with PD-L1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study
err2017-09-01
err25
errOAAI
errMehnert, J. M.; Rugo, H. S.; O'Neil, B. H.; Santoro, A.; Schellens, J. H. M.; Cohen, R. B.; Doi, T.; Ott, P. A.; Pishvaian, M. J.; Puzanov, I.; Aung, K. L.; Hsu, C.; Le Tourneau, C.; Soria, J-C.; Elez, E.; Tamura, K.; Gould, M.; Zhao, G.; Stein, K.; Piha-Paul, S. A.
errShare
errSave